Services
The Microbial Genome Sequencing Centers (MSCs) provide services for rapid and cost efficient production of high-quality, genome sequences of microorganisms considered agents of bioterrorism (NIAID Category A-C priority pathogens), related organisms, clinical isolates, closely related species, and invertebrate vectors of infectious diseases and microorganisms responsible for emerging and re-emerging infectious diseases.
In recent years the MSCs have begun several large collaborative sequencing initiatives including the:
NIAID will not accept unsolicited grant applications for large-scale DNA sequencing projects for microorganisms and invertebrate vectors of disease, including NIH cooperative agreement grant applications, which is a change in NIAID policy, effective December 2003.
Investigators wishing to apply for support to sequence an organism not described above must do so in the context of an investigator-initiated, hypothesis-driven, unsolicited research project application (R01), subject to standard NIH acceptance and peer-review procedures. NIAID will only accept such applications for review that contain a substantial research component beyond genome sequencing.